1. Home
  2. ASTE vs ABUS Comparison

ASTE vs ABUS Comparison

Compare ASTE & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASTE
  • ABUS
  • Stock Information
  • Founded
  • ASTE 1972
  • ABUS 2005
  • Country
  • ASTE United States
  • ABUS United States
  • Employees
  • ASTE N/A
  • ABUS N/A
  • Industry
  • ASTE Construction/Ag Equipment/Trucks
  • ABUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASTE Industrials
  • ABUS Health Care
  • Exchange
  • ASTE Nasdaq
  • ABUS Nasdaq
  • Market Cap
  • ASTE 1.1B
  • ABUS 906.7M
  • IPO Year
  • ASTE N/A
  • ABUS N/A
  • Fundamental
  • Price
  • ASTE $44.99
  • ABUS $4.50
  • Analyst Decision
  • ASTE Hold
  • ABUS Strong Buy
  • Analyst Count
  • ASTE 1
  • ABUS 2
  • Target Price
  • ASTE $41.00
  • ABUS $5.00
  • AVG Volume (30 Days)
  • ASTE 162.4K
  • ABUS 932.1K
  • Earning Date
  • ASTE 11-05-2025
  • ABUS 11-06-2025
  • Dividend Yield
  • ASTE 1.16%
  • ABUS N/A
  • EPS Growth
  • ASTE N/A
  • ABUS N/A
  • EPS
  • ASTE 2.08
  • ABUS N/A
  • Revenue
  • ASTE $1,368,800,000.00
  • ABUS $15,416,000.00
  • Revenue This Year
  • ASTE $6.81
  • ABUS $138.02
  • Revenue Next Year
  • ASTE $7.32
  • ABUS N/A
  • P/E Ratio
  • ASTE $21.63
  • ABUS N/A
  • Revenue Growth
  • ASTE 6.66
  • ABUS 53.23
  • 52 Week Low
  • ASTE $29.65
  • ABUS $2.71
  • 52 Week High
  • ASTE $50.83
  • ABUS $5.10
  • Technical
  • Relative Strength Index (RSI)
  • ASTE 40.40
  • ABUS 50.57
  • Support Level
  • ASTE $42.00
  • ABUS $4.29
  • Resistance Level
  • ASTE $46.56
  • ABUS $4.62
  • Average True Range (ATR)
  • ASTE 1.64
  • ABUS 0.21
  • MACD
  • ASTE -0.29
  • ABUS -0.02
  • Stochastic Oscillator
  • ASTE 43.63
  • ABUS 31.39

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: